Upcoming Webinars
2‑Part Live Webinar Series ISO 10993 Updates in Practice: From E&L Testing Challenges to ISO 10993‑1:2025 Revisions
Presented by Elisabet Jamez, Expert Advisory Services team at Nelson Labs and Wouter Buyssens, Scientific Project Manager at Nelson Labs
31st March 2026
Validating rCR on a Microfluidic Platform: A Multi-Matrix Approach
Presented by Meg Provenzano, Global Product Manager for Endotoxin at Veolia
14th April 2026
Automation, Traceability, Reliability: See Our LIMS in Action
Presented by Albane Flocon, Bioinformatics developer at genOway, Christel Merrouche, Head of preclinical processes at genOway and Stéphane Pitout - Director of Professional Sales (SciY)
22nd April 2026
Validation and Implementation of the Monocyte Activation Test as an Alternative Method to the Rabbit Pyrogen Test
Presented by Jonas Van Den Berg, Subject Matter Expert, Pyrogen Testing and Alternative Microbiological Methods at Roche, Luisa Burgmaier, Project Leader, Endotoxin and Pyrogen Testing Group at Microcoat Biotechnologie
13th May 2026
On Demand Webinars
Regulatory Challenges of Recent Low Endotoxin Recovery Regulatory Queries: Pfizer’s Strategy to Evaluate and Implement Global Changes to Meet Evolving Expectations
Presented by Jody Peraino MS, Principal Scientist, Pfizer, Allen L. Burgenson, Global Subject Matter Expert, Testing Solutions at Lonza
20th March 2026
Considerations for mRNA-LNP Potency Assay Development for Gene Editing Products
Presented by Benjamin Hall, Associate Director in Analytical Development at Tessera Therapeutics, Gargi Chaudhuri, Ph.D., Senior Field Applications Scientist, Bio-Techne (Protein Simple)
12th March 2026
Expanding Continuous Manufacturing at Pfizer, Enabling High Drug Load Formulations via Wet Granulation Technology
Presented by Travis Powell, Senior Principal Scientist at Pfizer
10th March 2026
Addressing Subvisible Silicone Oil Droplets-Industry Challenges, Analytical Strategies, and USP’s Rationale for a New General Informational Chapter
Presented by Desmond G Hunt, Senior Principal Scientist at US Pharmacopeia, Laura A. Philips, PhD, MBA President and Chief Executive Officer Spheryx, Inc., Tyler Carter, PhD. Senior Application Scientist, at Yokogawa Fluid Imaging Technologies Inc
04th March 2026
